Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac AmyloidosisGraham Lohrmann, Frederick L. Ruberg, Alexandra Pipilas et al.|Journal of Cardiac Failure|2019Cited by 106
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experienceOmar K. Siddiqi, Frederick L. Ruberg, Gheorghe Doros et al.|Amyloid|2022Cited by 46
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell TransplantationGraham Lohrmann, Deepa M. Gopal, Monica Patel et al.|JACC CardioOncology|2020Cited by 19
Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center ExperienceYuliya Mints, Omar K. Siddiqi, John L. Berk et al.|Circulation|2019Cited by 2
Abstract 15377: Stabilization of Cardiac Function in Wild-Type Transthyretin Cardiac Amyloidosis With DiflunisalGraham Lohrmann, Frederick L. Ruberg, Alexandra Pipilas et al.|Circulation|2018Cited by 0